Home Health & Hospice Week
New Drug Price List Offers Mixed Bag For Suppliers
The Centers for Medicare & Medicaid Services released its second-quarter Part B drug fees to ambivalent reviews from respiratory drug suppliers. While the fees for some staple drugs will rise, others will actually decline.
The good news: Fees for albuterol (HCPCS code J7613) will climb from 6.5 cents to 9 cents per milligram.
The not-so-good news: Fees for ipratropium bromide (J7644) will fall from 29 cents to 20.2 cents per milligram.
"I expected to see some changes upward, but I didn't expect to see any changes downward," Wayne Stanfield, executive director of the Home Care Alliance of Virginia, tells Eli.
The downward adjustment in the ipratropium bromide fee especially concerns Stanfield. It might lead some suppliers to stop offering the drug altogether, he warns.
Under the Medicare Modernization Act, Part B drugs fees are based on the average sales price plus 6 percent, updated quarterly. The recently released fees will be effective from April 1 through June 30, and are based on ASPs for the drugs during the fourth quarter of 2004.
Price hikes are also in store this quarter for concentrated levalbuterol (J7612), which is up by 2 cents to 89.1 cents per half-milligram; for levalbuterol unit dose (J7614), up 13.9 cents to $1.417 per half-milligram; and for albuterol compound solution, up 1.8 cents to $2.623 per unit.
But the price for the concentrated form of albuterol (J7611) will actually decrease slightly, from 7.1 cents to 6.9 cents per milligram.
The volatility in the drug fees after just one quarter of the new pricing system raises red flags for Stanfield.
"I was surprised to see as much change as there was," he says. "Perhaps manufacturers are not dealing with the new system very well."
Editor's note: The new drug fee schedule is at www.cms.hhs.gov/providers/drugs/asp.asp.
Home Health & Hospice Week
- Prospective Payment System:
Rural HHAs Face Expiration Of Add-On
Cut could push rural providers out of business, reps predict.
The financial picture is bleak for [...] - Competitive Bidding:
Brace For A Nationwide Bid Area For Mail Order DME
Controversy could throw a wrench into suppliers' bidding plans.
Heads up, durable medical equipment providers: Beginning [...] - Drugs:
New Drug Price List Offers Mixed Bag For Suppliers
Albuterol is up but ipratropium bromide is down, latest fee schedule indicates.
The Centers for Medicare [...] - Regulations:
Your Medicare Contractor Could Change Soon
Contracting reform will mean intermediary shuffle for some agencies.
Remember those Medicare contracting regions CMS announced [...] - Oasis:
Prevent Oasis-Based Downcodes Before They Happen
And you can still appeal this common denial.
Is your OASIS documentation costing you your rightful [...] - Medical Review:
Contractors Gear Up To Find Fault With Your Claims
CMS names Recovery Audit Contractors.
If you receive a medical review request from someone you've never [...] - Reimbursement:
Oxygen Rates To Drop 12%
The HHS Office of Inspector General has finally completed its study on Medicare oxygen rates, [...] - Industry Notes:
Accreditation Required For Suppliers, Despite Bidding Status
DME contractor reform delayed a bit, CMS also says in forum.
Durable medical equipment suppliers won't [...]
